Maria D. Carrabba

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Timing is everything: outcomes of allogeneic HSCT in adults with inborn errors of immunity.

Timing is everything: outcomes of allogeneic HSCT in adults with inborn errors of immunity.

Journal: Bone marrow transplantation

Published: April 26, 2026

Homozygosity for rare or common hypomorphic IL23R variants confers a predisposition to tuberculosis in humans.

Homozygosity for rare or common hypomorphic IL23R variants confers a predisposition to tuberculosis in humans.

Journal: bioRxiv : the preprint server for biology

Published: April 03, 2026

Humans homozygous for rare or common hypomorphic IL23R variants are prone to tuberculosis.

Humans homozygous for rare or common hypomorphic IL23R variants are prone to tuberculosis.

Journal: The Journal of experimental medicine

Published: October 27, 2025

Autosomal Dominant Hyper-IgE Syndrome Patients Retain IL10-Producing preTh17-Cells That Are Activated by Opportunistic Pathogens and Support IgE Production.

Autosomal Dominant Hyper-IgE Syndrome Patients Retain IL10-Producing preTh17-Cells That Are Activated by Opportunistic Pathogens and Support IgE Production.

Journal: Allergy

Published: June 23, 2025

Autoimmune Retinopathy in a Patient with Common Variable Immunodeficiency.

Autoimmune Retinopathy in a Patient with Common Variable Immunodeficiency.

Journal: Ocular immunology and inflammation

Published: May 20, 2025

Long-term efficacy and safety of colchicine and anti-IL-1 blockers in FMF: results from the Eurofever multicenter observational study.

Long-term efficacy and safety of colchicine and anti-IL-1 blockers in FMF: results from the Eurofever multicenter observational study.

Journal: Journal of autoimmunity

Published: February 22, 2025

Successful Treatment of PAPASH Syndrome With Concomitant FMF Using IL-1 Blockade: A Case Report.

Successful Treatment of PAPASH Syndrome With Concomitant FMF Using IL-1 Blockade: A Case Report.

Journal: International journal of dermatology

Published: December 09, 2024

MicroRNA dysregulation in ataxia telangiectasia.

MicroRNA dysregulation in ataxia telangiectasia.

Journal: Frontiers in immunology

Published: June 05, 2024

The dilemma of X-linked agammaglobulinemia carriers.

The dilemma of X-linked agammaglobulinemia carriers.

Journal: The journal of allergy and clinical immunology. Global

Published: May 31, 2024

COVID-19 Vaccination in Patients with Inborn Errors of Immunity Reduces Hospitalization and Critical Care Needs Related to COVID-19: a USIDNET Report.

COVID-19 Vaccination in Patients with Inborn Errors of Immunity Reduces Hospitalization and Critical Care Needs Related to COVID-19: a USIDNET Report.

Journal: Journal of clinical immunology

Published: August 02, 2023

SARS-CoV-2 pre-exposure prophylaxis with tixagevimab/cilgavimab (AZD7442) provides protection in inborn errors of immunity with antibody defects: a real-world experience.

SARS-CoV-2 pre-exposure prophylaxis with tixagevimab/cilgavimab (AZD7442) provides protection in inborn errors of immunity with antibody defects: a real-world experience.

Journal: Frontiers in immunology

Published: June 28, 2023

Preliminary Evidence of Good Safety Profile and Outcomes of Early Treatment with Tixagevimab/Cilgavimab Compared to Previously Employed Monoclonal Antibodies for COVID-19 in Immunocompromised Patients.

Preliminary Evidence of Good Safety Profile and Outcomes of Early Treatment with Tixagevimab/Cilgavimab Compared to Previously Employed Monoclonal Antibodies for COVID-19 in Immunocompromised Patients.

Journal: Biomedicines

Published: April 24, 2023

Showing 1-12 of 39

Last Updated: 09/26/2026